[et_pb_section fb_built=\u00bb1″ admin_label=\u00bbsection\u00bb _builder_version=\u00bb4.25.1″ custom_padding=\u00bb||0px|||\u00bb locked=\u00bboff\u00bb collapsed=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_row column_structure=\u00bb1_5,3_5,1_5″ _builder_version=\u00bb4.25.1″ _module_preset=\u00bbdefault\u00bb custom_margin=\u00bb10px||||false|false\u00bb custom_padding=\u00bb||0px|||\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb1_5″ _builder_version=\u00bb4.25.1″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_column][et_pb_column type=\u00bb3_5″ _builder_version=\u00bb4.25.1″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_image src=\u00bbhttps:\/\/ibima.eu\/wp-content\/uploads\/2025\/05\/MSCA-IBIMA.png\u00bb title_text=\u00bbMSCA IBIMA\u00bb align=\u00bbcenter\u00bb _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb width=\u00bb86%\u00bb module_alignment=\u00bbcenter\u00bb custom_margin=\u00bb26px|224px|||false|false\u00bb custom_padding=\u00bb|0px||||\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_image][\/et_pb_column][et_pb_column type=\u00bb1_5″ _builder_version=\u00bb4.25.1″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb min_height=\u00bb83px\u00bb custom_margin=\u00bb-1px|auto||auto|false|false\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.25.1″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_heading title=\u00bbMSCA-PF at Biomedical Research Institute of M\u00e1laga and Nanomedicine Platform BIONAND: Nutrition, endocrinology and coleroectal cancer\u00bb _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb title_text_align=\u00bbcenter\u00bb title_text_color=\u00bb#0C71C3″ title_line_height=\u00bb1.4em\u00bb module_alignment=\u00bbcenter\u00bb hover_enabled=\u00bb0″ global_colors_info=\u00bb{}\u00bb sticky_enabled=\u00bb0″][\/et_pb_heading][\/et_pb_column][\/et_pb_row][et_pb_row admin_label=\u00bbrow\u00bb _builder_version=\u00bb4.27.4″ background_size=\u00bbinitial\u00bb background_position=\u00bbtop_left\u00bb background_repeat=\u00bbrepeat\u00bb width=\u00bb77.1%\u00bb custom_margin=\u00bb|-436px||237px|false|false\u00bb custom_padding=\u00bb1px|0px||9px||\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.16″ custom_padding=\u00bb|||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_text admin_label=\u00bbText\u00bb _builder_version=\u00bb4.27.4″ header_text_color=\u00bb#000000″ background_size=\u00bbinitial\u00bb background_position=\u00bbtop_left\u00bb background_repeat=\u00bbrepeat\u00bb width=\u00bb100%\u00bb custom_margin=\u00bb1px|-295px|||false|false\u00bb hover_enabled=\u00bb0″ global_colors_info=\u00bb{}\u00bb sticky_enabled=\u00bb0″]<\/p>\n
The group \u00abEpiOncObesity: New Cellular and Molecular Mechanisms of Inflammation in Metabolic Diseases \u2013 Obesity, Diabetes, and Cancer,\u00bb<\/strong>\u00a0<\/span>led by Dr. Manuel Mac\u00edas at the BIONAND Centre in M\u00e1laga, is interested in hosting a Marie Sk\u0142odowska-Curie Postdoctoral Fellow (MSCA-PF).<\/p>\n Three MSCA-PF research proposals are available under the supervision of\u00a0<\/span>Dr. Manuel Mac\u00edas Gonz\u00e1lez<\/strong>.<\/p>\n Dr. Mac\u00edas Gonz\u00e1lez is a senior researcher in the IBIMA-A02 group within Area 1: Cardiovascular Diseases, Obesity, and Diabetes \u2013 Environmental Determinants and Lifestyle, at the\u00a0<\/span>Biomedical Research Institute of M\u00e1laga \u2013 IBIMA-BIONAND Platform<\/strong>. He has been affiliated with\u00a0<\/span>CIBERobn (Center for Biomedical Research in the Obesity and Nutrition Network)<\/strong>\u00a0<\/span>since 2007 and has served as\u00a0<\/span>Co-Principal Investigator<\/strong>\u00a0<\/span>in its Nutrition Research Program since 2021. Additionally, since 2020, he has coordinated the\u00a0<\/span>Cellular Biology Laboratory<\/strong>\u00a0<\/span>at the\u00a0<\/span>Virgen de la Victoria University Hospital<\/strong>\u00a0<\/span>in M\u00e1laga.<\/p>\n Since 2014, Dr. Mac\u00edas has been awarded multiple renewals under the\u00a0<\/span>Nicol\u00e1s Monardes Program<\/strong>, supporting high-level biomedical research in the\u00a0<\/span>Endocrinology and Nutrition Unit (HUVV)<\/strong>\u00a0<\/span>of the Andalusian Public Health System. Within this unit, he has established a multidisciplinary research team that obtained\u00a0<\/span>Optimal Quality Accreditation<\/strong>\u00a0<\/span>in 2022 and renewed it in 2024. His group\u2019s work has made significant contributions to both clinical practice and translational research.<\/p>\n Description of the center<\/strong>:\u00a0<\/span>IBIMA Platform BIONAND is a multidisciplinary research space in biomedicine and nanomedicine that is centered around the two largest hospitals located in Malaga (Regional and Virgen de la Victoria University Hospitals) and Primary Care Units of the Andalusian Public Health System, together with the biotechnological groups of the University of Malaga. This entity brings together 73 research groups, selected based on scientific excellence, and working on eight big research areas. IBIMA aims to promote research of excellence, oriented towards translational research, fostering transferable results to clinical practice, advancing in the improvement of prevention, diagnosis and treatment of the most prevalent health problems at the regional, national and international level. It enables the development and promotion of a space for cutting-edge research that contributes to the scientific basis of the programs and policies of the National Health System. In 2015, IBIMA obtained recognition from the National Ministry of Health as one of the Biomedical Research Institute of reference in Spain. In 2022, the\u00a0Andalusian Centre for Nanomedicine and Biotechnology (BIONAND) was integrated into IBIMA, equipped with a nanoimaging Unit holding the distinction of \u201cSingular Scientific and Technical Infrastructure\u201d awarded by the Spanish Government, infrastructure unique in Spain and one of the most complete in Europe. The Institute is part of relevant European research infrastructures such us EATRIS (Biomarkers and ATMP platforms) and ECRIN (designated in 2022 as National Hub of ECRIN-ERIC by the Spanish Government), and also participates in more than 80 scientific and technological research networks, being a European reference in biomedical and translational research.<\/span><\/p>\n Description of the Projects<\/strong><\/p>\n Number of Positions Available: 1 per project (total: 3 positions)<\/strong><\/p>\n Description Principal Investigator<\/strong><\/span>\u00a0<\/span>(education, research experience, publications, projects,\u00a0<\/span><\/em>ORCID ID<\/span><\/em><\/a>, Researcher ID or other, international background, etc.) \u00b8<\/span><\/em>\u00a0<\/span>https:\/\/orcid.org\/0000-0002-6475-4704<\/a><\/span><\/em><\/p>\n The Principal Investigator (PI) received predoctoral and postdoctoral training in Molecular Endocrinology at leading national and international biomedical research centers. He completed two postdoctoral stays between 1999 and 2003 at prestigious institutions: the Heinrich Heine University in D\u00fcsseldorf (Germany) and the University of Kuopio (Finland). In 2004, he was awarded a competitive Miguel Servet contract (ISCIII), later achieving senior researcher stabilization through the I3SNS-ISCIII program at IBIMA. In 2014, he obtained a position as a researcher linked to the Endocrinology and Nutrition Unit at the Virgen de la Victoria Hospital through the Nicol\u00e1s Monardes Program (Andalusian Health Department), with two subsequent renewals (2018 and 2023).<\/span><\/p>\n Since 2005, the PI has led five consecutive FIS-ISCIII research projects, consolidating a research line focused on:\u00a0<\/span>\u201cNew cellular and molecular mechanisms of inflammation in metabolic diseases: obesity, diabetes, and cancer\u201d<\/strong>. He is a founding member and co-leader of the M\u00e1laga node of CIBERobn (CB06\/03\/0018) and the IBIMA-A01 group on obesity, diabetes, and related comorbidities.\u00a0<\/span>Currently, he coordinates the Biomedical Research Laboratory at IBIMA-Plataforma Bionand in Virgen de la Victoria University Hospital.<\/span><\/p>\n The PI has an\u00a0<\/span>H-index of 40 (Google Scholar)<\/strong>, with over 100 peer-reviewed publications \u2014more than 50% as last or corresponding author in the last five years\u2014 in the fields of Endocrinology, Molecular Biology, Obesity, and Cancer. He has presented over 100 oral and written communications at national and international congresses (SEEDO, SEEN, ECE, EASO, ESMO, SEBBM), serving as organizer and moderator in several.<\/span><\/p>\n He has broad international experience as an expert evaluator for the EU and Ibero-America, and has participated in European projects (JPI, EASO), including as a management committee member in the\u00a0<\/span>COST Action CA16120 EPITRAN (2017\u20132021)<\/strong>. This initiative aimed to secure competitive European funding for his project EpiOncObesity, focusing on epigenetic mechanisms in adipogenesis and carcinogenesis.<\/span><\/p>\n In terms of technology transfer, the PI has participated in\u00a0<\/span>9 national patents<\/strong>, with\u00a0<\/span>3 internationalized and 1 commercially exploited<\/strong>. He has also collaborated with international companies in tech-focused research and co-founded a biotech spin-off at the University of M\u00e1laga. He holds certifications in animal experimentation and a Master\u2019s degree in biotech business training.<\/span><\/p>\n He has supervised\u00a0<\/span>6 PhD theses<\/strong>\u00a0<\/span>and numerous master’s and undergraduate projects across Spanish universities. He has taught at various academic levels since 2016 and has directed the\u00a0<\/span>Master\u2019s in Obesity and Diabetes at the University of M\u00e1laga<\/strong>\u00a0<\/span>since 2019. He promotes international training, mentoring Erasmus+ technical fellows and postdocs in\u00a0<\/span>Marie Curie (EU)<\/strong>\u00a0<\/span>and\u00a0<\/span>Fulbright (USA)<\/strong>\u00a0<\/span>programs.<\/span><\/p>\n As coordinator of the biomedical research lab, he has contributed to the development of hospital-based biomedical research infrastructure in M\u00e1laga, fostering multidisciplinary integration and advancing translational research in biomedicine.<\/span><\/p>\n [\/et_pb_text][et_pb_heading title=\u00bbApplication Details\u00bb _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb title_level=\u00bbh4″ title_font=\u00bb|||on|||||\u00bb title_text_align=\u00bbleft\u00bb title_text_color=\u00bb#0C71C3″ width=\u00bb98.8%\u00bb custom_margin=\u00bb8px||||false|false\u00bb custom_padding=\u00bb4px||0px|0px||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover_enabled=\u00bbon|desktop\u00bb custom_padding__hover=\u00bb4px||0px|0px||\u00bb][\/et_pb_heading][\/et_pb_column][\/et_pb_row][et_pb_row admin_label=\u00bbrow\u00bb _builder_version=\u00bb4.27.4″ background_size=\u00bbinitial\u00bb background_position=\u00bbtop_left\u00bb background_repeat=\u00bbrepeat\u00bb width=\u00bb77.1%\u00bb custom_margin=\u00bb|-259px||240px|false|false\u00bb custom_padding=\u00bb0px|0px||9px||\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.16″ custom_padding=\u00bb|||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_text admin_label=\u00bbText\u00bb _builder_version=\u00bb4.27.4″ header_text_color=\u00bb#000000″ background_size=\u00bbinitial\u00bb background_position=\u00bbtop_left\u00bb background_repeat=\u00bbrepeat\u00bb width=\u00bb100%\u00bb min_height=\u00bb121px\u00bb custom_margin=\u00bb0px|-78px|||false|false\u00bb custom_padding=\u00bb0px||0px|||\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n [\/et_pb_text][et_pb_heading title=\u00bbCandidate profile\u00bb _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb title_level=\u00bbh4″ title_font=\u00bb|||on|||||\u00bb title_text_align=\u00bbleft\u00bb title_text_color=\u00bb#0C71C3″ width=\u00bb98.8%\u00bb custom_margin=\u00bb-1px||||false|false\u00bb custom_padding=\u00bb4px||0px|0px||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover_enabled=\u00bbon|desktop\u00bb custom_padding__hover=\u00bb4px||0px|0px||\u00bb][\/et_pb_heading][et_pb_text admin_label=\u00bbText\u00bb _builder_version=\u00bb4.27.4″ header_text_color=\u00bb#000000″ background_size=\u00bbinitial\u00bb background_position=\u00bbtop_left\u00bb background_repeat=\u00bbrepeat\u00bb width=\u00bb100%\u00bb min_height=\u00bb90px\u00bb custom_margin=\u00bb0px|-78px|||false|false\u00bb custom_padding=\u00bb0px||0px|||\u00bb hover_enabled=\u00bb0″ global_colors_info=\u00bb{}\u00bb sticky_enabled=\u00bb0″]<\/p>\n Required education level:<\/strong><\/p>\n Required experience level:<\/strong><\/p>\n Required languages skills: <\/strong><\/p>\n Additional requirements:<\/strong><\/p>\n Specific requirements: Experience with handling and analyzing high-throughput sequencing data, ability to work independently and in multidisciplinary teams, knowledge of lab safety protocols<\/span><\/p>\n At the deadline for the submission of proposals researchers:<\/p>\n [\/et_pb_text][et_pb_heading title=\u00bbImportant and contac information\u00bb _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb title_level=\u00bbh4″ title_font=\u00bb|||on|||||\u00bb title_text_align=\u00bbleft\u00bb title_text_color=\u00bb#0C71C3″ width=\u00bb98.8%\u00bb custom_margin=\u00bb-1px||||false|false\u00bb custom_padding=\u00bb4px||0px|0px||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover_enabled=\u00bbon|desktop\u00bb custom_padding__hover=\u00bb4px||0px|0px||\u00bb][\/et_pb_heading][et_pb_text admin_label=\u00bbText\u00bb _builder_version=\u00bb4.27.4″ header_text_color=\u00bb#000000″ background_size=\u00bbinitial\u00bb background_position=\u00bbtop_left\u00bb background_repeat=\u00bbrepeat\u00bb width=\u00bb100%\u00bb min_height=\u00bb121px\u00bb custom_margin=\u00bb0px|-78px|62px||false|false\u00bb custom_padding=\u00bb0px||0px|||\u00bb hover_enabled=\u00bb0″ global_colors_info=\u00bb{}\u00bb sticky_enabled=\u00bb0″]<\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":" The group \u00abEpiOncObesity: New Cellular and Molecular Mechanisms of Inflammation in Metabolic Diseases \u2013 Obesity, Diabetes, and Cancer,\u00bb\u00a0led by Dr. Manuel Mac\u00edas at the BIONAND Centre in M\u00e1laga, is interested in hosting a Marie Sk\u0142odowska-Curie Postdoctoral Fellow (MSCA-PF). Three MSCA-PF research proposals are available under the supervision of\u00a0Dr. Manuel Mac\u00edas Gonz\u00e1lez. Dr. Mac\u00edas Gonz\u00e1lez is […]<\/p>\n","protected":false},"author":4,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"class_list":["post-53802","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"\n\n
\n
\n
\n
\n
\n
\n
\n
\n
<\/ul>\n<\/li>\n<\/ul>\n